Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.270
+0.005 (0.40%)
At close: Aug 7, 2026, 4:00 PM EDT
1.348
+0.078 (6.17%)
Pre-market: Aug 10, 2026, 8:07 AM EDT
Coherus Oncology Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $4 | Buy | Maintains | $4 | +214.96% | Aug 7, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +687.40% | Aug 7, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $10 | Buy | Maintains | $10 | +687.40% | Aug 6, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 | Buy | Reiterates | $7 | +451.18% | Aug 6, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 28, 2026 |